In this work, an innovative hybrid eutectogel-chitosan nanoparticles system was developed, suitable for biomedical applications. Chitosan (CS) was used as a matrix for the encapsulation of the naturally occurring flavonoid chrysin (Chr), known for its significant biological activities but with limited applications due to its very low aqueous solubility resulting in poor oral bioavailability. A natural deep eutectic solvent (NADES), namely choline chloride/lactic acid at a 1:2 molar ratio, was used as a multifunctional component in the preparation of chitosan nanoparticles (CS-NPs) for chrysin encapsulation, facilitating nanoparticle formation under the investigated conditions. The hydrodynamic diameter of the CS-Chr NPs was 138.8 nm, as determined using nanoparticle tracking analysis, with a high positive ζ-potential of +46.53 mV. The encapsulation efficiency of the CS-Chr NPs was 45%. CS-Chr NPs and blank-CS NPs were evaluated for their hemolytic properties and demonstrated hemolytic activity, within the limits of allowed nanotoxicity (hemolysis < 5%). Additionally, the NADES acted as a matrix, with xanthan gum functioning as a gelator, for the preparation of eutectogels. The resulting eutectogel was developed to combine the advantages of the NADES-based environment and chitosan–chrysin nanoparticles (CS–Chr NPs) with the structural integrity and prolonged retention provided by a gel matrix, thereby offering a stable and versatile platform for the localized delivery of chrysin. The prepared xanthan gum eutectogels showed significant swelling ratio capacity (120%) even after the swollen sample was kept in the aqueous HCl solution (pH 1.2) for 3 h, indicating a good stability of the network. The release of chrysin from CS-Chr NPs reached 94% after 8 h, and exhibited predominantly Fickian diffusion (n = 0.4099). Incorporation of the CS-Chr NPs into the xanthan-gum-based eutectogel resulted in a more sustained chrysin release (76% after 8 h). The eutectogel release was predominantly diffusion-driven (Higuchi, R2 = 0.9796), with anomalous transport (n = 0.7247) indicating an additional contribution of polymer relaxation and/or swelling. The proposed NADES-based platform provides a sustainable strategy for the development of multifunctional nanocomposite eutectogels, combining biocompatible components with the unique functional properties of natural deep eutectic solvents for advanced biomedical delivery applications.
No takes yet. Share an insight, caveat, or question.
Pitterou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: